Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000054

Director sold 35,000 shares at an average $70.13 ($2,454,382)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dambkowski Carl · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-11 Sale : show line 1 in the form 10b5-1 −22,417 $70.13 $1,572,201 51,326 D
2026-06-12 Sale : show line 2 in the form 10b5-1 −12,583 $70.11 $882,182 38,743 D
Open-market sales · 35,000 sh · avg $70.13 · $2,454,382
Loading xslF345X06/form4.xml…